Medicago’s Canada-made COVID-19 vaccine faces WHO rejection due to tobacco industry ties |

The primary COVID-19 vaccine manufactured by a Canadian firm will “very probably” not get the inexperienced mild for emergency use by the World Health Organization (WHO) on account of its ties to the tobacco trade.

Dr. Mariângela Simão, WHO’s assistant director-general for entry to medicines and well being merchandise, spoke in regards to the vaccine throughout a press briefing Wednesday.

“As a consequence of its connections — it’s owned by tobacco firm Philip Morris International — so the method is placed on maintain as a result of it’s well-known that the WHO and UN have a really strict coverage relating to engagement with tobacco and arms industries,” she stated. “So the method is on maintain.

“It’s very probably that it’s going to not be accepted for emergency listing utilizing by WHO.”

Learn extra:

Medicago’s Canada-made COVID-19 vaccine approved by Health Canada

Story continues beneath commercial

A steerage doc from WHO on its web site from March 2 exhibits the analysis course of for every COVID-19 vaccine submitted for evaluation. Medicago’s COVID-19 vaccine is listed as “not accepted” within the group’s expression of curiosity part.

The Quebec-based biopharmaceutical firm’s vaccine marks the world’s first-ever plant-based jab for human use. The vaccine, referred to as Covifenz, is comprised of two doses that should be administered 21 days aside, based mostly on proof from scientific trials.

The corporate submitted its final part of knowledge, which included 30,000 volunteers, for regulatory evaluation by Health Canada in December 2021. The latter permitted Medicago’s vaccine to be used in late February, for individuals aged between 18 and 64.

Canada has a contract to purchase as much as 76 million doses of Covifenz however its vaccine technique is now relying solely on mRNA vaccines from Pfizer-BioNTech and Moderna.

Click to play video: 'Health Canada approves Medicago, first homegrown COVID-19 vaccine'

Well being Canada approves Medicago, first homegrown COVID-19 vaccine

Well being Canada approves Medicago, first homegrown COVID-19 vaccine – Feb 24, 2022

If the WHO denies the applying it will forestall Canada from donating any of its Medicago doses to COVAX.

Story continues beneath commercial

Medicago stated in an announcement Thursday that it has not acquired any “official communication” from WHO so far.

“It’s our understanding that this choice is linked to Medicago’s minority shareholder and never the demonstrated security and efficacy profile of our COVID-19 vaccine,” president and CEO Takashi Nagao stated.

Learn extra:

Canada’s COVID-19 vaccine contender — Medicago’s breakthrough, ties to Big Tobacco and warnings a pandemic was coming

In July 2020, the corporate had introduced plans to distance itself from Philip Morris Worldwide. The affiliation has been a supply of roadblocks and criticism for Medicago.

Federal Well being Minister Jean-Yves Duclos stated Thursday the federal government is intently monitoring the scenario.

“We’re trying on the exchanges between WHO and Medicago,” Duclos stated.

“Minister Champagne and I’ve contacted Medicago to make it possible for its contact with WHO is finished correctly so that everybody not solely right here in Canada however elsewhere on this planet can reap the benefits of this new vaccination that has been permitted by Well being Canada and it may be good for lots of different people residing elsewhere on the planet.”

Representatives for Well being Canada haven’t instantly responded to a request to touch upon WHO’s choice.

Story continues beneath commercial

— with information from World Information’ Irelyne Lavery, Carolyn Jarvis, Emanuela Campanella, Nicole Gibillini and The Canadian Press

© 2022 World Information, a division of Corus Leisure Inc.

Leave a Comment